Propanc Biopharma Inc (PPCB)
0.0009
0.00 (0.00%)
USD |
OTCM |
May 21, 12:40
Propanc Biopharma Shareholders Equity (Quarterly): -3.700M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -3.700M |
December 31, 2023 | -3.564M |
September 30, 2023 | -2.989M |
June 30, 2023 | -3.117M |
March 31, 2023 | -2.941M |
December 31, 2022 | -2.915M |
September 30, 2022 | -2.768M |
June 30, 2022 | -3.024M |
March 31, 2022 | -2.947M |
December 31, 2021 | -2.930M |
September 30, 2021 | -2.307M |
June 30, 2021 | -3.068M |
March 31, 2021 | -3.004M |
December 31, 2020 | -3.608M |
September 30, 2020 | -3.236M |
June 30, 2020 | -3.641M |
March 31, 2020 | -4.847M |
December 31, 2019 | -5.672M |
September 30, 2019 | -4.542M |
June 30, 2019 | -4.301M |
March 31, 2019 | -3.413M |
December 31, 2018 | -3.904M |
September 30, 2018 | -5.558M |
June 30, 2018 | -6.752M |
March 31, 2018 | -6.773M |
Date | Value |
---|---|
December 31, 2017 | -7.149M |
September 30, 2017 | -6.738M |
June 30, 2017 | -5.442M |
March 31, 2017 | -4.715M |
December 31, 2016 | -3.841M |
September 30, 2016 | -1.804M |
June 30, 2016 | -2.565M |
March 31, 2016 | -3.521M |
December 31, 2015 | -3.356M |
September 30, 2015 | -3.182M |
June 30, 2015 | -3.054M |
March 31, 2015 | -1.851M |
December 31, 2014 | -1.877M |
September 30, 2014 | -1.784M |
June 30, 2014 | -1.408M |
March 31, 2014 | -1.165M |
December 31, 2013 | -1.050M |
September 30, 2013 | -1.218M |
June 30, 2013 | -0.7925M |
March 31, 2013 | -0.7478M |
December 31, 2012 | -0.6432M |
September 30, 2012 | -0.6096M |
June 30, 2012 | -0.5379M |
March 31, 2012 | 1.676M |
December 31, 2011 | 4.519M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-5.672M
Minimum
Dec 2019
-2.307M
Maximum
Sep 2021
-3.456M
Average
-3.092M
Median
Shareholders Equity (Quarterly) Benchmarks
Humanigen Inc | -49.72M |
Cantabio Pharmaceuticals Inc | -1.889M |
Affymax Inc | -- |
Statera BioPharma Inc | -10.24M |
Incannex Healthcare Inc | 14.14M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 0.0373M |
Total Liabilities (Quarterly) | 3.737M |